{
    "Trade/Device Name(s)": [
        "IDS-iSYS Intact PTHN"
    ],
    "Submitter Information": "Immunodiagnostic Systems Ltd",
    "510(k) Number": "K161158",
    "Predicate Device Reference 510(k) Number(s)": [
        "K103325"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CEW"
    ],
    "Summary Letter Date": "January 9, 2017",
    "Summary Letter Received Date": "January 11, 2017",
    "Submission Date": "January 9, 2017",
    "Regulation Number(s)": [
        "21CFR862.1545"
    ],
    "Regulation Name(s)": [
        "Parathyroid hormone test system"
    ],
    "Analyte Class(es)": [
        "endocrine",
        "chemistry"
    ],
    "Analyte(s)": [
        "Intact Parathyroid Hormone (PTH)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Red top tube",
        "SST (Serum Separator Tube)",
        "K2-EDTA tube",
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "IDS-iSYS Multi-Discipline Automated System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent kit",
        "Calibrator",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for IDS-iSYS Intact PTHN chemiluminescent immunoassay for quantitative determination of intact parathyroid hormone on IDS-iSYS Multi-Discipline Automated System",
    "Indications for Use Summary": "Quantitative determination of intact parathyroid hormone in human serum or plasma to aid in differential diagnosis of hypercalcemia and hypocalcemia related to disorders of calcium metabolism",
    "fda_folder": "Clinical Chemistry"
}